| id | C00002015 |
|---|---|
| Name | (-)-Anabasine |
| CAS RN | 494-52-0 |
| Standard InChI | InChI=1S/C10H14N2/c1-2-7-12-10(5-1)9-4-3-6-11-8-9/h3-4,6,8,10,12H,1-2,5,7H2/t10-/m0/s1 |
| Standard InChI (Main Layer) | InChI=1S/C10H14N2/c1-2-7-12-10(5-1)9-4-3-6-11-8-9/h3-4,6,8,10,12H,1-2,5,7H2 |
| Phytochemical cluster | No. 1 |
|---|---|
| KCF-S cluster | No. 2084 |
| By standard InChI | CHEMBL1526229 |
|---|---|
| By standard InChI Main Layer | CHEMBL280963 CHEMBL1496898 CHEMBL1526229 |
| By LinkDB | C06180 |
|---|
| By CAS RN | D000691 |
|---|
| class name | count |
|---|---|
| asterids | 11 |
| rosids | 3 |
| eudicotyledons | 2 |
| family name | count |
|---|---|
| Cornaceae | 5 |
| Solanaceae | 4 |
| Fabaceae | 3 |
| Berberidaceae | 1 |
| Asteraceae | 1 |
| Scrophulariaceae | 1 |
| Amaranthaceae | 1 |
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL1496898 CHEMBL1526229 |
CHEMBL1614110
(2)
CHEMBL1741321
(2)
|
1 / 0 |
| Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL280963 |
CHEMBL1613842
(1)
|
4 / 2 |
| P06746 | DNA polymerase beta | Enzyme | CHEMBL280963 |
CHEMBL1614079
(1)
|
0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL1496898 CHEMBL1526229 |
CHEMBL1614027
(1)
CHEMBL1741325
(2)
|
0 / 1 |
| P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | CHEMBL280963 |
CHEMBL751862
(1)
|
1 / 1 |
| P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | CHEMBL280963 |
CHEMBL751862
(1)
|
1 / 1 |
| P39748 | Flap endonuclease 1 | Enzyme | CHEMBL280963 |
CHEMBL1794486
(1)
|
0 / 0 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | CHEMBL280963 |
CHEMBL2114810
(1)
|
7 / 3 |
| P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | CHEMBL280963 |
CHEMBL751838
(1)
|
0 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL1526229 |
CHEMBL1741322
(2)
|
0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL1496898 CHEMBL1526229 |
CHEMBL1613777
(2)
CHEMBL1741323
(2)
|
1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1526229 |
CHEMBL1741324
(2)
|
0 / 1 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL1526229 |
CHEMBL1614211
(1)
|
0 / 0 |
| O00255 | Menin | Unclassified protein | CHEMBL1496898 CHEMBL1526229 |
CHEMBL1614531
(2)
|
2 / 5 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL1496898 CHEMBL1526229 |
CHEMBL1614531
(2)
|
1 / 3 |
| OMIM | preferred title | UniProt |
|---|---|---|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 |
P43681
|
| #605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 |
P17787
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| KEGG | disease name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
|
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) |
P17787
(related)
P43681 (related) |
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
| MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
|---|---|---|---|---|---|
| D001259 | D000691 | Ataxia |
marker/mechanism
|
23219611
|
|
| D006948 | D000691 | Hyperkinesis |
marker/mechanism
|
19366487
|
|
| D018908 | D000691 | Muscle Weakness |
marker/mechanism
|
23219611
|
|
| D014202 | D000691 | Tremor |
marker/mechanism
|
23219611
|